NYSE$CC

The Chemours · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Chemours' financial performance was reported for Q2 2024, with net sales of $1.5 billion and net income of $70 million.

Chemours reported Q2 2024 financial results with net sales of $1.5 billion, a 6% decrease year-over-year. Net income attributable to Chemours was $70 million, or $0.46 per diluted share, compared to a net loss of $376 million in the prior-year quarter. Adjusted EBITDA was $206 million, down from $324 million in the corresponding prior-year quarter.

  • Net Sales of $1.5 billion, down 6% year-over-year.
  • Net Income attributable to Chemours of $70 million, or $0.46 per diluted share, compared with a Net Loss attributable to Chemours of $376 million, or $2.52 per diluted share, in the corresponding prior-year quarter
  • Adjusted Net Income of $57 million, or $0.38 per diluted share, compared with $167 million, or $1.10 per diluted share, in the corresponding prior-year quarter
  • Received permit to expand Teflon™ PFA resin production under APM Performance Solutions; a critical material for semiconductor manufacturing

Headline financials

Total Revenue

$1.54B

Previous: $1.64B-6.4%
EPS

$0.46

Previous: $1.10-58.2%
Adjusted EBITDA

$207M

No prior period
TSS Adjusted EBITDA

$160M

No prior period
TSS Adjusted EBITDA Margin

31.0%

No prior period
TT Adjusted EBITDA

$83M

No prior period
TT Adjusted EBITDA Margin

12.0%

No prior period
APM Adjusted EBITDA

$45M

No prior period
APM Adjusted EBITDA Margin

13.0%

No prior period
Other Non-Reportable Adjusted EBITDA

$3M

No prior period
Corporate Expenses

$77M

No prior period
Net Leverage Ratio

4.4

No prior period
Operating Cash Flow

-$620M

No prior period
Capital Expenditures

$73M

No prior period
Free Cash Flow Conversion

-335.0%

No prior period
Free Cash Flow

-$105M

Previous: -$525M+80.0%
Net Income

$70M

Previous: -$376M+118.6%
Operating Income

$138M

Previous: -$396M+134.8%
Gross Profit

$306M

Previous: $410M-25.4%
Cash & Equivalents

$604M

Previous: $738M-18.2%
Total Assets

$7.25B

Previous: $7.66B-5.4%
R&D Expense

$26M

No prior period
Stock-Based Comp

$6M

Previous: $3M+100.0%

Revenue & EPS history

Chemours · Revenue · Quarterly

$1.54B

Q2 2024-6.4%vs Q2 2023
Beat estimate in 7 of 15 quarters(47%)
ActualEstimate

Forward guidance

The Company anticipates a low to mid-single digit sequential decline in Net Sales for the third quarter.

Tailwinds

  • Continued strong adoption of Opteon™ Refrigerants, with anticipated double-digit year-over-year growth
  • APM’s Performance Solutions portfolio showing strong year-over-year growth

Headwinds

  • Residual impacts from Q2 unplanned downtime at our Altamira, Mexico manufacturing site in TT
  • Refrigerant seasonality paired with weaker Freon™ Refrigerants pricing in TSS
  • A continued modest recovery in APM
  • Anticipates a high-single digit sequential decline in Adjusted EBITDA for the third quarter, reflecting approximately $15 to $20 million of costs related to the unplanned shutdown at Altamira

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

+1.4%

Avg return

Earnings day

+2.4%

Avg return

5 days after

+1.2%

Avg return

30 days after

55%

27 / 49 earnings

Positive

+24.2%

Q4 2019

Best reaction

-23.0%

Q2 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-15.7%-9.6%-26.8%
Q4 2025-16.5%-11.7%-13.3%
Q3 2025+6.8%+7.4%+8.2%
Q1 2025-9.4%-0.9%-8.1%
Q4 2024+3.9%-0.4%-12.8%
Q3 2024+11.6%+11.1%+19.4%
Q2 2024-15.0%-22.5%-19.6%
Q1 2024-6.1%-4.0%-7.6%
Q4 2023-4.1%+5.0%-0.2%
Q3 2023-0.1%+2.1%+11.7%
Q2 2023-4.8%-4.0%-14.8%
Q1 2023+6.4%+11.1%+4.4%
Q4 2022-1.7%-0.8%-10.7%
Q3 2022+1.0%-0.9%+13.5%
Q2 2022+4.0%+1.6%+4.5%
Q1 2022+17.7%+21.1%+31.7%
Q4 2021-16.8%-13.9%-26.9%
Q3 2021+8.0%+4.7%-3.0%
Q2 2021+1.9%+4.7%+6.5%
Q1 2021+4.4%+14.7%+23.0%
Q4 2020-2.6%-1.8%+7.1%
Q3 2020+2.2%+8.3%+23.0%
Q2 2020-0.3%+5.9%+12.8%
Q1 2020+12.9%+18.3%+44.4%
Q4 2019+24.2%+19.1%-33.9%
Q3 2019+13.9%+13.4%-11.1%
Q2 2019-23.0%-26.5%-25.7%
Q1 2019-1.8%-16.4%-39.4%
Q4 2018-2.6%-3.0%-2.2%
Q3 2018+4.1%+2.9%-13.7%
Q2 2018+4.9%+6.7%-2.8%
Q1 2018+4.5%+4.4%+1.7%
Q4 2017+2.7%+2.5%+4.5%
Q3 2017-8.4%-10.5%-9.0%
Q2 2017-1.6%+3.8%+4.3%
Q1 2017-1.0%+2.4%-0.7%
Q4 2016-0.5%+3.1%+8.4%
Q3 2016+12.7%+21.1%+52.3%
Q2 2016+13.2%+25.8%+49.6%
Q1 2015-3.1%
Q1 2016+9.6%
Q1 2014+2.3%
Q4 2013+2.3%
Q4 2015+14.3%
Q3 2014-17.2%
Q3 2015-17.2%
Q4 2014+16.3%
Q2 2014+16.3%
Q2 2015+16.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro